Management of glaucoma.
D000208:Acute Disease; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D002908:Chronic Disease; D005123:Eye / Q000187:drug effects; D005730:Ganglionic Blockers / Q000627:therapeutic use; D005901:Glaucoma / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D008916:Miotics / Q000627:therapeutic use; D009184:Mydriatics / Q000627:therapeutic use; D009900:Optic Nerve / Q000098:blood supply; D010830:Physostigmine / Q000494:pharmacology / Q000627:therapeutic use; D010862:Pilocarpine / Q000494:pharmacology / Q000627:therapeutic use; D011379:Prognosis; D014665:Vasodilator Agents / Q000627:therapeutic use
D002257:Carbonic Anhydrase Inhibitors; D005730:Ganglionic Blockers; D008916:Miotics; D009184:Mydriatics; D014665:Vasodilator Agents; D010862:Pilocarpine; D010830:Physostigmine